Petros Pharmaceuticals, Inc. Defined Contribution Plan, Employer Matching Contribution, Percent of Match
Petros Pharmaceuticals, Inc. (PTPI) reported Defined Contribution Plan, Employer Matching Contribution, Percent of Match of 100.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Compensation Related Costs › Defined Contribution Plan
us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch · last filed 2026-04-15
- Petros Pharmaceuticals, Inc. defined contribution plan, employer matching contribution, percent of match for fiscal 2025 was 100.00%, a 100.00% increase from fiscal 2024.
- Petros Pharmaceuticals, Inc. defined contribution plan, employer matching contribution, percent of match for fiscal 2024 was 50.00%, a 50.00% decline from fiscal 2023.
- Petros Pharmaceuticals, Inc. defined contribution plan, employer matching contribution, percent of match for fiscal 2023 was 100.00%, a 0.00% change from fiscal 2022.
- Petros Pharmaceuticals, Inc. defined contribution plan, employer matching contribution, percent of match for fiscal 2022 was 100.00%, a 0.00% change from fiscal 2021.
| Period end | Defined Contribution Plan, Employer Matching Contribution, Percent of Match 12 month | Defined Contribution Plan, Employer Matching Contribution, Percent of Match 12 month as first filed |
|---|---|---|
| 2025-12-31 | 100.00% 10-K · filed 2026-04-15 | |
| 2024-12-31 | 50.00% 10-K · filed 2026-04-15 | 100.00% 10-K · filed 2025-03-31 |
| 2023-12-31 | 100.00% 10-K · filed 2024-04-01 | |
| 2022-12-31 | 100.00% 10-K · filed 2023-03-31 | |
| 2021-12-31 | 100.00% 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |